Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Post by Captainblkon Dec 21, 2019 4:20pm

70 Views

Post# 30480210

🤡🤡 CLOWN ALERT ! DAVIDDAWKINS555 is trying to scam 🤡🤡

This ROOKIE scammer cant even answer a simple question on why they are hellbent on seeing a lifesaving treatment fail. My guess is they are a potential buyer BEGGING to weaken KLY's negotiating position with a PATHETIC MISINFORMATION CAMPAGIN Doesn't matter what news comes out, they try to spin it in a way to scare you, with no explanation WHY they are here or care. Extremely suspicious

Bullboard Posts

How one company is disrupting PoC testing